Literature DB >> 21332006

Extraordinarily elevated serum levels of CA 19-9 and rapid decrease after successful therapy: a case report and review of literature.

Murat Korkmaz1, Hakan Ünal, Haldun Selçuk, Uğur Yilmaz.   

Abstract

Carbohydrate antigen 19-9 is most valuable as a serum marker for pancreatic and biliary cancer, but increased concentrations occur in several other gastrointestinal malignancies. A carbohydrate antigen 19-9 value of >1,000 U/ml usually indicates a digestive cancer and has been reported to have a specificity greater than 99% for pancreatic cancer; nevertheless, false-positive results owing to benign diseases such as pancreatitis or liver cirrhosis have been noted. We present a patient with cholelithiasis and choledocholithiasis with acute cholangitis who had very high serum levels of carbohydrate antigen 19-9 (9586 IU/ml). The rapid decrease in carbohydrate antigen 19-9 after successful treatment was as interesting as the pretreatment high serum level of carbohydrate antigen 19-9.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21332006     DOI: 10.4318/tjg.2010.0139

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  7 in total

1.  Serum level of Ca 19-9 increases ability of IgG4 test to distinguish patients with autoimmune pancreatitis from those with pancreatic carcinoma.

Authors:  Marianne J van Heerde; J Buijs; B E Hansen; M de Waart; C H J van Eijck; G Kazemier; C J Pek; J W Poley; M J Bruno; E J Kuipers; H R van Buuren
Journal:  Dig Dis Sci       Date:  2014-01-03       Impact factor: 3.199

2.  Adjusting CA19-9 values to predict malignancy in obstructive jaundice: influence of bilirubin and C-reactive protein.

Authors:  Gaetano La Greca; Maria Sofia; Rosario Lombardo; Saverio Latteri; Agostino Ricotta; Stefano Puleo; Domenico Russello
Journal:  World J Gastroenterol       Date:  2012-08-21       Impact factor: 5.742

3.  Haemophagocytic lymphohistiocytosis presenting as liver failure following Epstein-Barr and prior hepatitis A infections.

Authors:  Gineth Paola Pinto-Patarroyo; Michael E Rytting; John Moore Vierling; Maria E Suarez-Almazor
Journal:  BMJ Case Rep       Date:  2013-08-13

4.  Predictors of malignancy in pancreatic head mass: a prospective study.

Authors:  Arjun Sivaraman; Arjun Sivarman; Ashok Muthukrishnan; Nagendra Boopathy Senguttvan; Suraj Anil Suchak; Umashankkar Kannan
Journal:  Pan Afr Med J       Date:  2011-07-19

5.  Dilemmas and limitations interpreting carbohydrate antigen 19-9 elevation after curative pancreatic surgery: A case report.

Authors:  Grace Gold; Su Kah Goh; Christopher Christophi; Vijayaragavan Muralidharan
Journal:  Int J Surg Case Rep       Date:  2018-11-20

6.  Serum Carbohydrate Antigen 199 as a Biomarker for Evaluating Patients with Choledocholithiasis.

Authors:  Wang Gu; Zhong Tong
Journal:  Gastroenterol Res Pract       Date:  2020-03-25       Impact factor: 2.260

7.  Comparative study of CEA and CA19-9 in esophageal, gastric and colon cancers individually and in combination (ROC curve analysis).

Authors:  Bhawna Bagaria; Sadhna Sood; Rameshwaram Sharma; Soniya Lalwani
Journal:  Cancer Biol Med       Date:  2013-09       Impact factor: 4.248

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.